688513 苑东生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.2198.9888.97710.41010.596
总资产报酬率 ROA (%)1.7667.0627.1208.5118.761
投入资产回报率 ROIC (%)2.0648.2248.2479.94610.283

边际利润分析
销售毛利率 (%)79.15574.92580.01383.25585.990
营业利润率 (%)20.43918.66921.63922.26623.868
息税前利润/营业总收入 (%)19.82217.65320.63221.50723.755
净利润/营业总收入 (%)19.82417.65020.28221.06122.722

收益指标分析
经营活动净收益/利润总额(%)73.89474.37068.39065.41456.310
价值变动净收益/利润总额(%)7.1439.80410.54310.62717.027
营业外收支净额/利润总额(%)-0.0910.241-0.0400.5191.120

偿债能力分析
流动比率 (X)3.3653.2342.8483.2284.114
速动比率 (X)3.0052.9162.6052.9623.874
资产负债率 (%)20.16520.65222.21118.99217.425
带息债务/全部投入资本 (%)5.0934.1498.9493.8781.095
股东权益/带息债务 (%)1,818.5522,252.0251,001.0032,435.0878,836.862
股东权益/负债合计 (%)395.906384.207350.236426.547473.874
利息保障倍数 (X)-33.119-16.641-20.659-24.583-62.008

营运能力分析
应收账款周转天数 (天)52.25139.69341.42938.34841.127
存货周转天数 (天)285.141186.713243.347224.584235.768